Alzinova (ALZ.ST) Stock Price

Alzinova Price

OMX·CLOSED
0.43
​
Market closed

Revenue at Alzinova has contracted by 30.1% per year over the past 12 years to 30,000.00 SEK. For Alzinova, the net margin of -68,510.0% is down versus -43.6% a few years ago.

Alzinova stock price

Access this data via the Eulerpool API

Alzinova business model & stock analysis

Alzinova AB engages in the research and development of drugs for treatment of Alzheimer's disease. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2015-11-25. The firm is engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease. The firm focuses on development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric Aβ that damages brain synapses.

Frequently asked questions about Alzinova

5 analysts currently rate the Alzinova stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Alzinova to generate revenue of 31.35 M SEK and earnings per share of -0.22 SEK.

Converted at the current exchange rate, the Alzinova share trades at 0.04 EUR (0.43 SEK).

The Alzinova share (ALZ.ST) is listed on 3 stock exchanges, including: Frankfurt (78D.F), Stockholm (ALZ.ST).

The expected revenue of Alzinova is 31.35 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Alzinova is -23.37 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Alzinova is currently -1.99. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Alzinova stock.

The price-to-sales ratio (P/S) of Alzinova is currently 1.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Alzinova stock.

The Eulerpool Quality Score for Alzinova is 2/10.

The ISIN of Alzinova is SE0007413455. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Alzinova is A2N87T. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Alzinova is ALZ.ST. The ticker symbol is used to trade Alzinova shares on the stock exchange.

Fair ValueTerminal
0.36 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website alzinova.com
Country
Sweden
Currency
SEK
Initial public offering
Nov 25, 2015
ISIN
SE0007413455
Cusip
W1R97M109
Market capitalization
72.44 M SEKMicro Cap
52-Week Range
PEG
-0.07
P/E ratio
P/Ee 2026
-1.99
P/Ee 2027
-1.03
P/Ee 2028
-1.03
P/Se
1.49
EV/EBIT
—
P/B Ratio
0.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.40 %
Last updated Oct 10, 2026, 7:04 AM

Alzinova Peer Group

Alzinova Ticker

FRANKFURT · 78D.FSTOCKHOLM · ALZ.STSTOCKHOLM · ALZ.ST

Alzinova FIGI

ALZ:SF · BBG00B4QSSH3ALZSEK:EP · BBG00X5V0X73ALZSEK:EZ · BBG00X5V0XS0ALZSEK:XS · BBG00X5V0XW5ALZSEK:X2 · BBG00X5V0XX4ALZSEK:XH · BBG00X5V0XZ2ALZSEK:XF · BBG00X5V0Y17ALZSEK:XE · BBG00X5V0Y35ALZSEK:XJ · BBG00X5V0Y44ALZSEK:XL · BBG00X5V0Y53ALZSEK:XG · BBG00X5V0Y62ALZSEK:XO · BBG00X5V0Y71

All fundamentals and in-depth analysis of Alzinova

Our stock analysis for Alzinova stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alzinova. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.